Trusted News Discovery Since 2008
{{/content}}
New Study Raises More Questions About J&J COVID Vaccine
Video Credit: CBS 2 New York
Published on July 21, 2021 - Duration: 02:01s
New Study Raises More Questions About J&J COVID Vaccine
The Delta variant is now responsible for 83% of new COVID cases in the U.S. Now, a preliminary study not yet peer reviewed suggests the Johnson & Johnson vaccine may not be as effective against the variant as Modern and Pfizer.
CBS2's Dr. Max Gomez explains.
You are here
Related videos from verified sources
New CDC assessment of delta variant 02:50
Video credit: ABC 10 News | San Diego - Published on July 31, 2021
NYC Mayor Offers $100 Incentive for Vaccinations at City-Run Sites 01:31
Video credit: Wibbitz Top Stories - Published on July 30, 2021
Water Vapor Is Discovered for First Time on Jupiter's Moon, Ganymede 01:30
Video credit: Wibbitz Top Stories - Published on July 30, 2021